Angiotensin II Receptor Blockers - Index

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.

• Revision history
  • Jan. 20, 2023
  • Jan. 22, 2021
  • Dec. 2018
  • Dec. 2016
  • Oct. 2014
  • Dec. 2012
  • March 2011
  • April 2008
  • July 2003
  • July 2002
  • Sept. 2001
  • Sept. 2000
  • July 1999
  • June 1998
  • July 1997
  • Dec. 1996
• Initially developed
  • April 1996